Market & Alt Data
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | 2026-05-21 | VOLL MARK | Chief Financial Officer | Purchase | 25.0K | $0.79 | $20K | 142.4K | View | |
| 2026-03-20 | 2026-03-24 | Marton Laurence | Director | Purchase | 9,720 | — | — | 9,720 | View | |
| 2026-03-20 | 2026-03-24 | Bagai Shaun | Director & Chief Executive Officer | Purchase | 24.3K | — | — | 313.4K | View | |
| 2026-03-20 | 2026-03-24 | VOLL MARK | Chief Financial Officer | Purchase | 97.2K | — | — | 97.2K | View | |
| 2026-01-21 | 2026-01-22 | Agah Ramtin | Director & Chief Medical Officer | Purchase | 10.0K | $1.00 | $10K | 798.5K | View |
Informational purposes only, not investment advice.
tormere.com/research/RNXT · generated 2026-11-07
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-05-19 | VOLL MARK | P | 25,000 | $19,690 |
| 2026-03-20 | Marton Laurence | P | 9,720 | — |
| 2026-03-20 | Bagai Shaun | P | 24,300 | — |
| 2026-03-20 | VOLL MARK | P | 97,200 | — |
| 2026-01-21 | Agah Ramtin | P | 10,000 | $9,975 |
Tormere — informational purposes only, not investment advice.